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ABSTRACT
Medicinal plant products are the natural products which have been very useful for human to cure various ailments and as an alternative medicine 
for conventional therapy. However, bacteria in natural environments are mainly exist in biofilm formation and are more susceptible to cause severe 
infections than the planktonic counterparts. Biofilm is associated with impaired epithelization and granulation tissue formation and also promotes 
a low-grade inflammatory response that interferes with wound healing. Since the infection caused by biofilm is often very difficult to treat, there is 
a need to find a new active anti-biofilm agent. In recent past, interest in the therapeutic and nutritional properties of various medicinal plants and 
its natural phytochemical compounds which have established for their anti-biofilm activities has been increased gradually. In this review, we have 
described various aerial parts of medicinal plants which have anti-biofilm effect which was evaluated against biofilm producing different bacterial 
pathogens and antimicrobial agents which are responsible to cure wound healing.
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INTRODUCTION
Bacterial biofilm is defined as microbes derived sessile communities of 
microorganism attached to the living or inert surface and is embedded in 
the extracellular polymeric substances (EPS) [1]. The role of the biofilm is 
to attach to the epithelia layer of multicellular organisms, abiotic surfaces, 
and interfaces between air and water. Some bacterial biofilms have been 
reported to have useful effects on food chains, sewage treatment of plants, 
to eliminate petroleum oil or hydrocarbon spillage from the oceans and 
human chronic bacterial infections. In 1970s, the research on biofilm 
has been extensive, with significant evidence showing that bacteria exist 
predominantly as a biofilm phenotype in medical, natural and industrial 
ecosystem [2]. Today, biofilm is implicated in numerous bacterial infections 
including those associated with the urinary tract, ear, sinuses, cystic 
fibrosis, indwelling catheters, chronic wounds, and periodontal disease.
Biofilm is often characterized by surface attachment, structural 
heterogenicity, genetic diversity, complex community interaction, and 
an extracellular matrix of polymeric substances. Single celled organisms 
generally exhibit two different modes of behaviors [3]. Mostly bacterial 
embedded biofilms arrive in a stationary phase, during these phase 
physicochemical interactions take place and produced a slime layer, 
followed by these lower diffusion of active molecules, and then a lesser 
susceptibility of antimicrobial killing [4]. The bacterial biofilm shows 
a different metabolic state than planktonic bacteria, mainly during 
transcription and cell interaction. The mode of biofilm growth results 
in an increased bacterial resistance against antimicrobial agent and host 
defense mechanism is now well-documented, and these was highlights 
the importance of effective biofilm management in chronic infections [3].
LIFE CYCLE OF BIOFILMS
The life cycle of biofilm contains four general stages: First the cells 
are adhere to a substrate such as polysaccharides or glycoprotein and 
form microcolonies [5]. As more as cell aggregates, the concentration 
of chemical signals reaches a point that triggers genetic changes in the 
cells that cause them to bind tightly to the surface and neighboring cells. 
These microcolonies produce a thick extracellular matrix composed 
of exopolysaccharides (EPS), protein, extracellular DNA and other 
polymer that forms a protective physical barrier around the bacteria, 
allowing them to grow into a mature biofilm of complex communities 
that are capable of chemical communication, a process called quorum 
sensing (QS). QS molecules have been shown to be essential for biofilm 
formation [6,7].
Once the biofilm reaches particular cell density, point of saturation, 
biofilm turns off the expression of gene producing EPS products 
and reactivates flagella motility genes to disperse new planktonic 
cells from disseminating biofilm in search of new environment [8]. 
The relationship between the host and its microbial communities is 
carefully balanced, but under certain conditions, it can break down 
and result in infectious diseases. Microbes of biofilm secrete specific 
toxins, generate a hypoxemic microenvironment, and the host immune 
system, from all of which may contribute to delayed wound healing [9]. 
According to a recent publication announcement from the National 
Institutes of Health, more than 60% of all microbial infections are 
caused by biofilms [10].
The exploration for alternative therapies is a required and using 
nowadays, for examples, animal or natural plant products, and/or 
combination with antibiotics or synthetic compounds seems to be one 
of the auspicious solutions [11]. Drugs which are derived from natural 
sources are major interest, and thus they are focused for activity against 
biofilm producing microorganism. Till now, 80% of human bacterial 
infections are formed by biofilm-associated, mostly infections are 
frequently being caused by Staphylococcus epidermidis, Staphylococcus 
aureus, Escherichia coli, and Pseudomonas aeruginosa [12].
Plant-based compounds are widely accepted due to the perception 
that they are safe, easily available, less expensive, and also have no side 
effects. Plant-based drugs have greater potential for producing new 
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drugs and used in traditional medicine to treat the immune booster, 
chronic and several infectious diseases. The World Health Organization 
estimated that about 80% of the world populations depends on 
traditional herbal medicine for their primary healthcare [13]. There 
are approximately 500,000 plant species occurring worldwide and 
<1% has been screened for biological active compound [14].
Plant has the ability to synthesize a wide variety of phytochemical 
compounds as secondary metabolites. Many of the phytochemical have 
been used to effectively treatment of various ailments for humanity. 
The different chemical and components extracts of many plants have 
been proved to be possible sources for new drugs [5]. The plant-
derived substances are under research for possible application in 
pharmaceutical industry includes crude extracts of leaves, stems, barks, 
root, essential oils, and novel compounds isolated from any of these 
sources. The effects of plant extracts to prevent biofilm formation and 
adherence have been shown in earlier studies [8].
Nowadays biofilm is considered major target for pharmacological 
development of drugs. For example, in future it may be possible to 
formulate wound care products, such as rinses or dressing, debridement 
pads, gel, anti-biofilm agent that penetrate through biofilm EPS, 
thus exposing the bacteria and increasing their susceptibility to 
antimicrobials. This review can be contribute to the development of a 
new approach to prevent and to treat biofilm infections (Table 1).
CONCLUSION
Large group of traditional medicinal plants is used for different 
medicinal properties, which have a greater potential to cure various 
diseases. Furthermore, various extracts from different medicinal plant 
parts such as leaves, flowers, essential oils, root, and barks were also 
found to possess the anti-biofilm activity. Nowadays, it is known that 
resistance to antibiotic is often caused by biofilm formation of microbial 
pathogens. Therefore, the development of effective and safe medicine 
properties of plant extracts, which have antimicrobial activity have 
developed in both academic and industrial sectors. In this review, we 
have described that various aerial parts of traditional medicinal plants 
were able to inhibit the biofilm formation from various strains, were 
isolated from different infection sources such as wound, septicemia, 
urinary tract infections showing its potential value as an alternative 
to anti-infection agent. Thus, there remaining tremendous scope for a 
further research study of these traditional medicinal plants to establish 
their therapeutic efficacy and molecular mechanism of anti-biofilm 
effect of the bioactive compound.
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Table 1: List of medicinal plants which have anti-biofilm activity
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Aerva lanata Leaves Methanol, 
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Arctium lappa Leaf Ethanol Diuretic, 
diaphoretic, blood 
purifying agent
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Flowers Water Measles, smallpox, 
jaundice, 
costiveness, 
ointment for wound, 
ulcer, frostbite, skin 
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